美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corgi Genomics & Precision Medicine ETF

34.15

+0.24570.72%

盤後：33.90-0.2457-0.72%16:10 EDT

成交量：89

成交額：3,051

市值：256.10萬

市盈率：- -

高：34.15

開：33.90

低：34.15

收：33.90

52周最高：36.54

52周最低：23.88

股本：7.50萬

流通股本：7.50萬

量比：0.10

換手率：0.12%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞公告

Twinstrand案判決：Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細

Twinstrand：特拉華州法院於8月21日裁定公司及華盛頓大學在針對Guardant Health的專利侵權訴訟中勝訴

A股異動 | 華大智造(688114.SH)早盤漲20%封漲停基因測序有望成為mRNA個性化腫瘤疫苗「底層基礎設施「

福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？

TradingKey中文

賽默飛世爾科技(TMO)股票8月19日盤中上漲3.67%：投資者必看的核心信息

TradingKey中文

第3次更新-足球——謝菲爾德聯隊前所有者獲准申請清算當初收購該俱樂部的那家公司

龔正會見美國賽默飛世爾科技董事長，希望公司深度融入上海生物醫藥產業生態

商務部李成鋼會見美國賽默飛世爾科技公司全球總裁江志成

Illumina信貸協議：具備增加最高5億美元承諾或定期貸款選擇權——SEC文件披露

美股異動 | 因競爭對手的藥物研發未達目標福泰製藥(VRTX.US)漲近7%

美股異動 | 因競爭對手的藥物研發未達目標福泰製藥(VRTX.US)漲近7%

福泰製藥(VRTX)股票8月10日開盤上漲9.76%：投資者必看的核心信息

TradingKey中文

Vertex Pharma股價上漲，因競爭對手的遺傳性疾病藥物研發遭遇挫折

賽默飛世爾預計，隨着生物製藥領域研發和生產的提振，其在印度的客户數量將增長15%至20%

迄今最全質量最高的人類基因組序列構建完成

Devyser與意大利實驗室簽署合作協議

LivaNova：預計交易將逐步提升氧合器產能，增強滿足客户未滿足需求的能力

Vertex 擴大領導團隊，為下一階段增長注入強勁動力

受診斷業務需求強勁推動，Revvity上調年度利潤和營收預期

非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/GNMX/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":34.1467,"timestamp":1789156800000,"preClose":33.901,"halted":0,"volume":89,"hourTrading":{"tag":"盘后","latestPrice":33.901,"preClose":34.1467,"latestTime":"16:10 EDT","volume":6,"amount":204.8802,"timestamp":1789157404565,"change":-0.2457,"changeRate":-0.007195,"amplitude":0},"delay":0,"changeRate":0.007247573817881459,"floatShares":75000,"shares":75000,"eps":0,"marketStatus":"休市中","change":0.2457,"latestTime":"09-11 16:00:00 EDT","open":33.901,"high":34.1467,"low":34.1467,"amount":3051,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":33.901,"nav":33.89,"aum":2541750,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.901,"preClose":34.1467,"latestTime":"16:10 EDT","volume":6,"amount":204.8802,"timestamp":1789157404565,"change":-0.2457,"changeRate":-0.007195,"amplitude":0},"volumeRatio":0.09619540473038417,"impliedVol":0.2416,"impliedVolPercentile":0.4125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":75000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.09619540473038417,"shares":75000,"dividePrice":0,"high":34.1467,"amplitude":0,"preClose":33.901,"low":34.1467,"week52Low":23.88,"pbRate":"--","week52High":36.5366,"institutionHeld":0,"latestPrice":34.1467,"eps":0,"divideRate":0,"volume":89,"delay":0,"ttmEps":0,"open":33.901,"prevYearClose":25.56,"prevWeekClose":35.2788,"prevMonthClose":35.0802,"prevQuarterClose":31.0879,"fiveDayClose":35.48,"twentyDayClose":32.1748,"sixtyDayClose":26.5628},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1127912643","title":"Twinstrand案判決：Guardant Health須按季度向公司及承銷商彙報11款產品與服務的全美銷售明細","url":"https://stock-news.laohu8.com/highlight/detail?id=1127912643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127912643?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"根据Twinstrand方面的消息，法院判决要求Guardant Health必须履行一项新的义务——按季度提交其在美国市场上全部11款产品与服务的销售账目，以供公司与承销商查阅。\n这一判决意味着，Guardant Health在运营透明度和合规性上将面临更为严格的监督。具体而言，公司需定期整理并呈报相关销售数据，确保各方能够及时掌握其业务动态。\n此举无疑为市场参与者提供了更清晰的视角，去审视这家精准医疗领域领军企业的真实业绩表现。季度汇报机制的建立，或将进一步影响投资者对该公司未来走势的评估与判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","BK4588","BK4551","BK4196","BK4585","EKG","LU0320765992.SGD","PTH","GNMX","BK4535","FFOX","GDOC","LFSC","HELX","GNOM","LU0109394709.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136746995","title":"Twinstrand：特拉華州法院於8月21日裁定公司及華盛頓大學在針對Guardant Health的專利侵權訴訟中勝訴","url":"https://stock-news.laohu8.com/highlight/detail?id=1136746995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136746995?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"Twinstrand宣布，特拉华州法院已于8月21日作出判决，支持公司及华盛顿大学的立场，认定其在针对Guardant Health提起的专利侵权诉讼中占据优势。这一裁决标志着这场备受关注的法律纠纷取得了阶段性胜利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HELX","BK4196","BK4585","LFSC","GDOC","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4551","FFOX","BK4535","GNOM","PTH","GNMX","EKG","GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660790477","title":"A股異動 | 華大智造(688114.SH)早盤漲20%封漲停 基因測序有望成為mRNA個性化腫瘤疫苗「底層基礎設施「","url":"https://stock-news.laohu8.com/highlight/detail?id=2660790477","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660790477?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:36","pubTimestamp":1787193395,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，华大智造开盘后快速封涨停。截至发稿，涨20%，报69.11元，成交额4.28亿元。消息面上，Moderna与默沙东联合研发的个性化mRNA癌症疫苗在大型三期临床试验中取得成功，引爆全球mRNA肿瘤疫苗赛道。这意味着，基因测序作为个性化肿瘤疫苗\"底层基础设施\"的价值，正迎来战略重估。公开资料显示，华大智造为国产基因测序龙头。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482415.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399300","GNMX","02827","07233","159646","159982","03188","82846","BK0251","83130","83188","WDNA","02846","688114","BK1147","HELX","SYNB","03130","GNOM","GDOC","HTEC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后，福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期，公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级，平均目标价达 563.25 美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU1035775433.USD","LU2324357040.USD","LU2468319806.SGD","VRTX","LU0432979614.USD","BBH","LU1778281490.HKD","IE00B19Z3B42.SGD","LU2237438978.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","IE0002270589.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU1585245621.USD","IDNA","IE0009355771.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","IE00B19Z9Z06.USD","LU2456880835.USD","LU0417517546.SGD","LU2462157665.USD","IBB","LU1093756325.SGD","GNMX","LU0079474960.USD","LU0256863811.USD","PBE","BIB","LU2362541513.USD","BK4588","LU1674673428.USD","LU0823416689.USD","BK4532","LU2417539215.USD","LU0234570918.USD","BK4139","LU2362541273.HKD","IBBQ","LU0109394709.USD","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU1674673691.USD","BK4567","LU2236285917.USD","LU0289739699.SGD","LU0320765992.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660276144","title":"賽默飛世爾科技(TMO)股票8月19日盤中上漲3.67%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2660276144","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660276144?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 01:16","pubTimestamp":1787159803,"startTime":"0","endTime":"0","summary":"• 在公布强劲的第二季度财务业绩后，赛默飞世尔上调了全年业绩预期。\n• 该公司以超过10亿美元的价格将其微生物业务出售给 Astorg。\n• 机构投资经理和对冲基金近期新建了该公司的仓位。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118681-market-movers-tmo-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0061474960.USD","BK4534","LU2360108059.USD","LU2089984988.USD","IE00BQXX3C00.GBP","LU0122379950.USD","LU1280957306.USD","LU1061106388.HKD","LU1989771016.USD","LU2125909247.SGD","LU0266013472.USD","LU2764263039.SGD","GNMX","IE00B19Z8X17.USD","LU1720051108.HKD","LU2357305700.SGD","BK4585","TMO","IE0002141913.USD","IE0009355771.USD","LU2298321311.HKD","LU0011850046.USD","LU1548497426.USD","LU1623119135.USD","LU2125909916.SGD","IE00BJJMRZ35.SGD","LU1815333072.USD","LU0208291251.USD","LU2112291526.USD","LU1267930573.SGD","HRTS","LU1633808545.USD","LU0114720955.EUR","LU1670627923.USD","LU1670628061.USD","LU1923622614.USD","LU1923621640.USD","LU1983299246.USD","BK4548","LU0345770308.USD","LU1064131342.USD","LU0957791311.USD","LU2468319806.SGD","LU1803068623.USD","LU0640476718.USD","BK4581","LU0708994859.HKD","FMED","TMED","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421558","title":"第3次更新-足球——謝菲爾德聯隊前所有者獲准申請清算當初收購該俱樂部的那家公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421558","media":"路透中文","labels":["policyRegulatory","merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421558?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 22:49","pubTimestamp":1787150961,"startTime":"0","endTime":"0","summary":"第3次更新-足球——谢菲尔德联队前所有者获准申请清算当初收购该俱乐部的那家公司在第4至5段中补充了谢菲尔德联队的声明路透伦敦8月19日-谢菲尔德联队前所有者周三获准申请，将清算该公司——该公司在2024年收购了这支英冠球队。谢菲尔德联队表示，高等法院的裁决对俱乐部而言并非问题。但今年6月，谢菲尔德联队表示1919 Partners LLC是该俱乐部的母公司，对此，United World本周表示，此举“似乎是试图逃避向CSBL的债权人付款”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4S44G1AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","GNOM","LU0109394709.USD","LU0320765992.SGD","FFOX","PTH","GH","LFSC","BK4588","HELX","BK4535","LU0889565916.HKD","GNMX","EKG","GDOC","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447650","title":"龔正會見美國賽默飛世爾科技董事長，希望公司深度融入上海生物醫藥產業生態","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447650","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447650?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 19:07","pubTimestamp":1787137652,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1988902786.USD","IE00B1BXHZ80.USD","LU0061474960.USD","XBI","LU1803068623.USD","LU1670627923.USD","BK4588","LU1720051017.SGD","LU1623119135.USD","LU2125909593.SGD","HRTS","IE00B19Z8W00.USD","LU0266013472.USD","BK4585","IE0002141913.USD","LU0310800379.SGD","LU1791710400.SGD","LU1989771016.USD","TMO","LU2092937221.SGD","LU0882574055.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","LU0957791311.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","GNMX","BK4121","GB00BDT5M118.USD","LU0557290698.USD","LU1291159041.SGD","LU1923621640.USD","IE0034235188.USD","LU0122379950.USD","LU0320765489.SGD","FMED","LU0208291251.USD","LU1057294990.SGD","LU1633808545.USD","BK4533","LU1983299246.USD","TMED","LU1280957306.USD","LU2125910336.SGD","IE00BQXX3F31.USD","LU0528227936.USD","BK4548","LU2063271972.USD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660548502","title":"商務部李成鋼會見美國賽默飛世爾科技公司全球總裁江志成","url":"https://stock-news.laohu8.com/highlight/detail?id=2660548502","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660548502?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 17:08","pubTimestamp":1786957719,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1057294990.SGD","LU2264538146.SGD","BK4534","LU0128525929.USD","LU2211814178.USD","BK4121","IE00BQXX3C00.GBP","LU1280957306.USD","IE00B19Z8W00.USD","LU1989771016.USD","LU0266013472.USD","LU2125910179.SGD","GNMX","LU2764263039.SGD","LU1720051108.HKD","LU2357305700.SGD","BK4585","TMO","LU0011850046.USD","LU1548497426.USD","LU1854104046.USD","LU1291159041.SGD","IE00BQXX3D17.EUR","LU0029864427.USD","IE00BJJMRZ35.SGD","LU2543165471.USD","IE00B4R5TH58.HKD","LU2433249047.HKD","HRTS","LU0114720955.EUR","LU0823416689.USD","LU0320765489.SGD","LU1923621640.USD","BK4533","LU2041044095.USD","LU1064131342.USD","IE00B2B36J28.USD","LU2764262908.HKD","PICK","IE00BFTCPJ56.SGD","LU1803068623.USD","LU0528227936.USD","BK4581","LU0708994859.HKD","FMED","LU0316494557.USD","LU1023059063.AUD","LU1061106388.HKD","TMED","LU2211815571.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198487728","title":"Illumina信貸協議：具備增加最高5億美元承諾或定期貸款選擇權——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1198487728","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198487728?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 04:24","pubTimestamp":1786652678,"startTime":"0","endTime":"0","summary":"Illumina公司提交的SEC文件显示，其信贷协议中包含一项可选条款。该条款允许公司将承诺额度或定期贷款规模提升至5亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ILMN","BK4535","LU0029874061.USD","GNOM","BK4585","LU0128526141.USD","GNMX","BK4548","BK4534","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658930620","title":"美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658930620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658930620?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 23:39","pubTimestamp":1786376356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VRTX","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU1035775433.USD","IBBQ","LU0058720904.USD","LU1585245621.USD","LU0889565916.HKD","PBE","IE00BZ9MQY76.HKD","LU2089984988.USD","BBH","BK4585","LU0289739699.SGD","IE0009355771.USD","LU2236285917.USD","LU1674673691.USD","IE00B19Z3581.USD","IBB","LU2417539215.USD","SG9999013999.USD","BK4567","IE00B19Z9Z06.USD","LU1778281490.HKD","TBXU","BK4139","LU1093756168.USD","GNMX","LU2324357040.USD","LU2362541513.USD","SGXZ57979304.SGD","IDNA","LU1430594728.SGD","LU2456880835.USD","LU0417517546.SGD","LU1069344957.HKD","LU1674673428.USD","BK4588","SG9999001176.USD","LU2462157665.USD","SG9999001176.SGD","IBBJ","IE00B19Z9P08.USD","IE0002270589.USD","LU0234570918.USD","LU2362540622.SGD","IE0002141913.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658793062","title":"美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658793062","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658793062?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 23:39","pubTimestamp":1786376356,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，$福泰制药(VRTX)$(VRTX.US)早盘涨近7%，创历史新高;而竞争对手$Sionna Therapeutics(SION)$(SION.US)暴跌超90%，创记录新低。消息面上，SION表示，由于SION-719实验性囊性纤维化药物在中期临床试验中未能达到主要目标，公司将终止该药物的研发。投资者此前一直担忧SION可能对VRTX的核心囊性纤维化业务构成威胁，但此次试验失败消除了这一担忧。VRTX公司销售的Trikafta和Alyftrek用于治疗囊性纤维化——这是一种罕见、慢性且会缩短寿命的遗传性疾病，会导致肺部进行性损伤。","market":"us","thumbnail":"https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478244.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1674673428.USD","IE00BJJMRZ35.SGD","LU1778281490.HKD","BBH","LU0417517546.SGD","LU2468319806.SGD","BIB","LU1430594728.SGD","LU1093756168.USD","LU2362541273.HKD","SGXZ57979304.SGD","LU1585245621.USD","LU0058720904.USD","BK4532","LU0234570918.USD","LU1674673691.USD","IE00B19Z9Z06.USD","LU2456880835.USD","IBB","IE00BZ9MQY76.HKD","SG9999001176.SGD","LU0320765992.SGD","VRTX","PBE","IE00BFTCPJ56.SGD","LU2236285917.USD","LU0061475181.USD","LU2462157665.USD","LU0079474960.USD","IE0002141913.USD","SG9999001176.USD","SG9999013999.USD","LU2417539215.USD","LU0109394709.USD","IDNA","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU2362541513.USD","BK4139","IBBJ","IBBQ","TBXU","GNMX","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0256863811.USD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","IE00B894F039.SGD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658934147","title":"福泰製藥(VRTX)股票8月10日開盤上漲9.76%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2658934147","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658934147?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 21:48","pubTimestamp":1786369694,"startTime":"0","endTime":"0","summary":"• 福泰制药（Vertex）公布了其非阿片类疼痛治疗候选药物的积极III期临床数据。\n• 在产品于国际市场成功上市后，该公司上调了全年营收指引。\n• 分析师维持“买入”评级，平均目标价为557.64美元。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262092811-market-movers-vrtx-20260810","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IE0002141913.USD","BK4139","GNMX","IE00BJT1NW94.SGD","TBXU","IDNA","LU1093756325.SGD","BIB","BBH","LU1430594728.SGD","SG9999001176.SGD","LU2089984988.USD","BK4533","LU0061475181.USD","LU2324357040.USD","LU2236285917.USD","LU2362541273.HKD","LU0320765992.SGD","BK4567","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU1035775433.USD","IE00BJJMRZ35.SGD","BK4532","IE00B19Z3581.USD","LU1585245621.USD","LU0889565916.HKD","VRTX","LU0432979614.USD","BK4588","IBBQ","SG9999013999.USD","BK4585","LU2362540622.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2456880835.USD","IBB","LU0234570918.USD","LU0256863811.USD","IE0002270589.USD","LU1778281490.HKD","LU2237438978.USD","LU2462157665.USD","LU0823416689.USD","SG9999001176.USD","LU2362541513.USD","PBE","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658398169","title":"Vertex Pharma股價上漲，因競爭對手的遺傳性疾病藥物研發遭遇挫折","url":"https://stock-news.laohu8.com/highlight/detail?id=2658398169","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658398169?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 20:36","pubTimestamp":1786365394,"startTime":"0","endTime":"0","summary":"BUZZ-Vertex Pharma股价上涨，因竞争对手的遗传性疾病药物研发遭遇挫折8月10日-** 制药公司Vertex Pharmaceuticals（VRTX.O）的股价在盘前交易中上涨7.65%，至534美元** Sionna Therapeutics（SION.O） (link) 表示，由于SION-719实验性囊性纤维化药物在中期临床试验中未能达到主要目标，公司将终止该药物的研发** ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4T4470W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","IE00B19Z3581.USD","LU0109394709.USD","GNMX","IE00B894F039.SGD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU1778281490.HKD","BIB","LU0417517546.SGD","LU0889565916.HKD","IE0002141913.USD","LU0256863811.USD","LU0061475181.USD","BK4567","IE00BZ9MQY76.HKD","LU0320765992.SGD","BBH","LU2324357040.USD","IE00B4R5TH58.HKD","BK4588","IE00B19Z9P08.USD","VRTX","LU1093756168.USD","SG9999001176.SGD","LU1069344957.HKD","BK4533","LU0058720904.USD","LU2456880835.USD","BK4532","SION","LU1674673691.USD","IBBQ","SG9999001176.USD","LU0432979614.USD","IBB","SGXZ57979304.SGD","LU1035775433.USD","IDNA","LU2236285917.USD","IE00B2B36J28.USD","PBE","SG9999013999.USD","LU2237438978.USD","LU0823416689.USD","TBXU","LU1674673428.USD","LU2462157665.USD","IE0002270589.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658867879","title":"賽默飛世爾預計，隨着生物製藥領域研發和生產的提振，其在印度的客户數量將增長15%至20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658867879","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658867879?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 16:07","pubTimestamp":1786349279,"startTime":"0","endTime":"0","summary":"赛默飞世尔预计，随着生物制药领域研发和生产的提振，其在印度的客户数量将增长15%至20%Rishika Sadam路透海得拉巴8月10日-赛默飞世尔科技印度分公司负责人表示，该公司计划在未来五年内将印度客户群扩大15%至20%，并押注于不断发展的生物制药研发与制造生态系统。该公司表示，受生物制药、半导体和清洁能源领域需求增长的推动，其在印度的业务有望持续实现两位数增长。赛默飞世尔为全球客户提供服务，美国是其主要市场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4S4470DK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345770993.USD","LU1803068623.USD","LU0266013472.USD","LU1815333072.USD","IE00BJT1NW94.SGD","LU0096362180.USD","LU1854104046.USD","LU0640476718.USD","LU2764262908.HKD","LU1923622291.USD","IE00BQXX3F31.USD","BK4581","BK4548","LU0557290698.USD","LU1064131342.USD","LU2543165471.USD","LU1989771016.USD","LU0345770308.USD","LU0208291251.USD","LU2125910179.SGD","IE00BQXX3D17.EUR","IE0034235188.USD","LU0882574055.USD","GNMX","GB00BDT5M118.USD","LU2357305700.SGD","LU2211814178.USD","HRTS","LU2360108059.USD","LU1548497426.USD","LU2112291526.USD","LU0234572021.USD","LU2089984988.USD","LU1988902786.USD","LU2092937221.SGD","TMO","TMED","LU1983299246.USD","LU1670628061.USD","IE00B1BXHZ80.USD","FMED","IE0002141913.USD","BK4588","LU2125909247.SGD","LU2764263203.CNY","LU0070302665.USD","LU0342679015.USD","LU2720916845.USD","BK4121","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661049","title":"迄今最全質量最高的人類基因組序列構建完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661049","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661049?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 07:22","pubTimestamp":1786058531,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GNMX","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173257026","title":"Devyser與意大利實驗室簽署合作協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1173257026","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173257026?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 14:40","pubTimestamp":1785998440,"startTime":"0","endTime":"0","summary":"8月6日，瑞典分子诊断公司Devyser Diagnostics AB宣布，已签署其首个商业试剂租赁协议。该协议在意大利落地，作为其与Illumina合作的一部分。此举标志着Devyser在全球市场拓展中迈出关键一步，尤其在南欧的意大利市场。通过这一合作，Devyser将提供基于Illumina平台的定制化试剂解决方案，旨在提升实验室的检测效率和灵活性。协议的具体财务条款尚未披露，但此类租赁模式通常能为客户降低初始投资成本，同时确保试剂供应的稳定性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4535","GNOM","BK4548","BK4534","BK4588","GNMX","LU0029874061.USD","ILMN","BK4121","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178169770","title":"LivaNova：預計交易將逐步提升氧合器產能，增強滿足客户未滿足需求的能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1178169770","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178169770?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 18:15","pubTimestamp":1785924909,"startTime":"0","endTime":"0","summary":"LivaNova宣布，一项交易预计将有助于逐步提升其氧合器的产量。随着时间的推移，这一举措将显著增强公司满足客户潜在且尚未被满足的订单需求的能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TMO","LU2112291526.USD","LU2543165471.USD","LU2065171402.SGD","LU1854103824.USD","LU0208291251.USD","LU0320765489.SGD","LFSC","LU0345770993.USD","LU2264538146.SGD","IE00B19Z9505.USD","LU2764262908.HKD","LU2211814178.USD","LU1623119135.USD","LU0122379950.USD","LU0342679015.USD","LU1983299246.USD","BK4548","LU2357305700.SGD","LU1720051017.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","GNMX","LU0823416689.USD","LU1791710400.SGD","IE00B1BXHZ80.USD","LU1670628061.USD","IE0002141913.USD","IE00BQXX3F31.USD","LU0011850046.USD","LU0345770308.USD","LU1815333072.USD","LU1280957306.USD","BK4533","LU1023059063.AUD","IE00BQXX3C00.GBP","IE00BKPKM429.USD","LU1633808545.USD","LU0528227936.USD","BK4082","BK4121","BK4566","LU1988902786.USD","GB00BDT5M118.USD","LU2041044095.USD","LU2125910179.SGD","LU2211815571.USD","LU1791710582.SGD","LU0061474960.USD","LU0114720955.EUR","IE00BQXX3D17.EUR","LU2125909593.SGD","LU1548497426.USD","LU1712237335.SGD","LU1803068623.USD","LIVN","LU1989771016.USD","LU2065169927.USD","LU1057294990.SGD","LU1923622291.USD","TMED","BK4588","LU2764263203.CNY","LU2764263039.SGD","LU2433249047.HKD","LU2065171311.SGD","LU1153585028.USD","LU2468319806.SGD","LU2720916845.USD","LU0096362180.USD","LU0432979614.USD","LU0557290698.USD","LU1720051108.HKD","LU1291159041.SGD","LU2298321311.HKD","BK4585","LU2063271972.USD","BK4581","LU1923622614.USD","IE0034235188.USD","LU1061106388.HKD","LU0957791311.USD","LU0234572021.USD","LU1670627923.USD","LU1923621640.USD","LU1854104046.USD","LU2089984988.USD","IE00B19Z8W00.USD","BK4534","LU1064131342.USD","LU2125910336.SGD","IE00B19Z8X17.USD","LU0640476718.USD","LU2125909916.SGD","LU0070302665.USD","LU2125909247.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","HRTS","IE00B2B36J28.USD","LU2092937221.SGD","LU0316494557.USD","LU0266013472.USD","FMED","LU2065170008.USD","LU2125909759.SGD","LU0882574055.USD","BK4535","LU2360108059.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117517951","title":"Vertex 擴大領導團隊，為下一階段增長注入強勁動力","url":"https://stock-news.laohu8.com/highlight/detail?id=1117517951","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117517951?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 20:02","pubTimestamp":1785844955,"startTime":"0","endTime":"0","summary":"宾夕法尼亚州普鲁士王，2026年8月4日——全球间接税与合规领域的“决策到防御”先锋，Vertex Inc.，今日宣布其领导团队迎来三位新成员，旨在为公司下一阶段的蓬勃发展提供坚实支撑。他们的加入，将通过对人才、区域运营及技术创新的领导力扩展，进一步强化 Vertex 的全球增长战略。在 Vertex，她将负责全球人才与企业文化战略，构建起推动业务规模化发展所需的人才储备和组织能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","TBXU","LU1069344957.HKD","PW","LU1559883803.SGD","BK4555","LU1674673428.USD","BK4099","LU0079474960.USD","BK4604","BK4023","VRTX","LU2456880835.USD","IBB","LU0823416689.USD","PBE","LU0109394709.USD","IE0002141913.USD","GNMX","IE00BJT1NW94.SGD","VERX","BBH","LU1430594728.SGD","LU2236285917.USD","LU2362541273.HKD","BK4567","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","TISI","BK4532","LU0889565916.HKD","LU0432979614.USD","BK4588","BK4585","LU2362540622.SGD","IE0009355771.USD","BK4120","LU0256863811.USD","LU2237438978.USD","LU1778281490.HKD","LU2462157665.USD","IE00B19Z3B42.SGD","LU2362541513.USD","TM","BK4084","BK4139","BK4234","LU1093756325.SGD","BIB","IE00B894F039.SGD","BK4533","03160","LU0061475181.USD","LU0757428866.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B19Z9Z06.USD","LU1815336091.USD","IE00BJJMRZ35.SGD","IBBQ","IE00B19Z9P08.USD","SGXZ57979304.SGD","IE0002270589.USD","LU0289739699.SGD","SG9999001176.USD","LU1093756168.USD","LU0058720904.USD","IDNA","SG9999001176.SGD","LU2089984988.USD","LU1674673691.USD","LU2468319806.SGD","LU1035775433.USD","LU0566484027.USD","IE00B19Z3581.USD","LU1585245621.USD","SG9999013999.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656053712","title":"受診斷業務需求強勁推動，Revvity上調年度利潤和營收預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2656053712","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656053712?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 18:51","pubTimestamp":1785840687,"startTime":"0","endTime":"0","summary":"受诊断业务需求强劲推动，Revvity上调年度利润和营收预期路透8月4日-医疗设备制造商Revvity周二上调了年度利润和营收预期，此前受其药物研发工具和诊断检测产品需求改善的推动，该公司第二季度业绩超出华尔街预期。Revvity的诊断业务第二季度营收同比增长11%，达到3.71亿美元。Revvity还签署了一项协议，计划出售其在中国市场的免疫诊断业务，理由是该国诊断市场持续疲软。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4T4410UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTS","GNMX","IE00BJT1NW94.SGD","LU0122379950.USD","LU1061106388.HKD","LU2125909916.SGD","LU2041044095.USD","LU1153585028.USD","RVTY","LU0316494557.USD","LU1670628061.USD","LU2543165471.USD","LU1291159041.SGD","LU1633808545.USD","LU1923622614.USD","BK4535","LU2360108059.USD","LU1791710400.SGD","LU2764262908.HKD","LU2125909593.SGD","TMED","LU0342679015.USD","IE00B1BXHZ80.USD","LU2468319806.SGD","LU0070302665.USD","IE00B2B36J28.USD","LU2764263039.SGD","LU2092937221.SGD","LU2433249047.HKD","LU1923622291.USD","LU0432979614.USD","BK4581","IE00B4R5TH58.HKD","BK4121","LU1064131342.USD","LU0266013472.USD","LU2211814178.USD","IE00BQXX3C00.GBP","TMO","LU2125909247.SGD","FMED","IE00B19Z9505.USD","BK4533","IE00BN0W2V16.EUR","LU0528227936.USD","LU1548497426.USD","LU1854104046.USD","IE00BQXX3D17.EUR","LU0882574055.USD","LU2125910179.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656539622","title":"非阿片止痛藥新鋭Latigo(LTGO.US)IPO擬最高募資2.88億美元，Nav1.8抑制劑劍指福泰製藥(VRTX.US)百億市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2656539622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656539622?lang=zh_tw&edition=fundamental","pubTime":"2026-08-04 16:59","pubTimestamp":1785833974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999013999.USD","IE00BJJMRZ35.SGD","BIB","LU2324357040.USD","LU0823416689.USD","BBH","BK4532","BK4585","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0058720904.USD","LTGO","BK4127","BK4533","KCE","LU2362541513.USD","LU1674673428.USD","BK4139","IE00BZ9MQY76.HKD","IE00BFTCPJ56.SGD","IDNA","IPOS","IE00BJT1NW94.SGD","IE00B19Z3581.USD","LU0289739699.SGD","REDS","TBXU","IE0002141913.USD","VRTX","LU2456880835.USD","PBE","FRHC","IBB","LU1430594728.SGD","IE00B19Z9Z06.USD","LU0889565916.HKD","GNMX","LU1093756325.SGD","LU1585245621.USD","IBBQ","LU2362541273.HKD","LU0256863811.USD","BK4588","LU0417517546.SGD","LU0234570918.USD","LU1093756168.USD","LU1778281490.HKD","LU2468319806.SGD","IE00B19Z9P08.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":71,"code":"91000000","status":"200"}]}}